ICAM1 and neoplasm: The two most important of these phenotypic changes include the expression of MHC class II molecules on the tumor cells, as first described by Prescott et al. [29] in 1989, and the expression of intracellular adhesion molecule-1 (ICAM-1) on the tumor cells, following BCG administration [30].